| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2002.46 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2540.92 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 1286.54 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 1946.87 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2259.41 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 1310.3 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2443.23 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2312.35 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 4160.09 | 99 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2958.95 | 99 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2440.26 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 4176.83 | 99 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1223.83 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2522 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2187.72 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1262.85 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2545.32 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2066.74 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2804.88 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2585.38 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2916.91 | 99 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2904.22 | 99 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2605.41 | 98 |